Protein Assays Companies

Thermo Fisher Scientific The industry leader expanded its protein assay portfolio with the launch of the QIAcube Connect automated ELISA workflow system. This system simplifies and streamlines ELISA testing for improved efficiency and accuracy.

Roche Diagnostics received FDA approval for its Elecsys BRAF V600E Mutation Test, a protein assay used to detect BRAF mutations in melanoma patients, aiding in targeted treatment decisions.

Luminex Corporation announced a collaboration with Promega Corporation to develop multiplex protein assays for biomarker discovery and validation in various disease areas.

Meridian Bioscience acquired Quidel Corporation, strengthening its position in the rapid diagnostic testing market, including protein-based assays for infectious diseases.

Abcam launched a new line of single-cell protein assays for analyzing protein expression patterns in individual cells, aiding in research on cell differentiation and disease mechanisms.

List of Protein Assays Key Companies in the Market

• GE Healthcare (U.S.)


• Thermo Fisher Scientific (U.S.)


• Bio-Rad Laboratories Inc. (U.S.)


• Merck KGaA (Germany)


• Cell Signaling Technology Inc. (U.S)


• Abcam plc (U.S.)


• Lucigen Corporation (U.S.)


• PerkinElmer Inc. (U.S.)


• QIAGEN (Germany)